STERILE WATER FOR INJECTION

STERILE WATER FOR INJECTION was reported 5483 times

STERILE WATER FOR INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYSOSOMAL STORAGE DISORDER 7 0.3684
1 PLASMA CELL MYELOMA IN REMISSION 3 0.0577
2 HEREDITARY ANGIOEDEMA 607 0.0565
3 PANTOEA AGGLOMERANS INFECTION 4 0.0519
4 PRODUCT COMPOUNDING QUALITY ISSUE 16 0.0438
5 HYDROSALPINX 4 0.0435
6 GLYCOGEN STORAGE DISEASE TYPE II 4 0.0381
7 THYROID STIMULATING IMMUNOGLOBULIN INCREASED 3 0.0375
8 USE OF ACCESSORY RESPIRATORY MUSCLES 14 0.0339
9 DEAFNESS PERMANENT 6 0.0306
10 CATHETER SITE DISCOMFORT 2 0.0250
11 CATHETERISATION VENOUS 2 0.0244
12 IN VITRO FERTILISATION 4 0.0221
13 CATHETER SITE THROMBOSIS 6 0.0219
14 OVARIAN HYPERSTIMULATION SYNDROME 50 0.0214
15 CATHETER REMOVAL 7 0.0196
16 WRONG PRODUCT STORED 5 0.0176
17 CENTRAL VENOUS CATHETER REMOVAL 8 0.0171
18 GRANULOCYTE COUNT DECREASED 31 0.0167
19 ENTEROBACTER TEST POSITIVE 4 0.0163
20 CATHETER SITE VESICLES 3 0.0154
21 GLOBOTRIAOSYLSPHINGOSINE INCREASED 3 0.0153
22 LIP INFECTION 3 0.0142
23 VASCULAR ACCESS COMPLICATION 11 0.0136
24 PRODUCT RECONSTITUTION QUALITY ISSUE 12 0.0134
25 PACKAGING DESIGN ISSUE 4 0.0122
26 CATHETER SITE IRRITATION 4 0.0120
27 DRUG LABEL CONFUSION 3 0.0120
28 VASCULAR DEVICE OCCLUSION 4 0.0118
29 PRODUCT PACKAGING CONFUSION 27 0.0111
30 ALLERGY TO PLANTS 5 0.0109
31 ENDOCRINE OPHTHALMOPATHY 9 0.0104
32 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 4 0.0099
33 ANHIDROSIS 4 0.0098
34 DEVICE RELATED BACTERAEMIA 3 0.0097
35 POOR VENOUS ACCESS 92 0.0089
36 INFUSION SITE DISCOMFORT 9 0.0087
37 NEONATAL INFECTION 3 0.0087
38 STIFF PERSON SYNDROME 3 0.0086
39 CATHETER SITE SWELLING 8 0.0085
40 FACIAL DISCOMFORT 6 0.0085
41 MEDICAL DEVICE SITE INFECTION 5 0.0081
42 PRODUCT BARCODE ISSUE 3 0.0078
43 PRODUCT APPEARANCE CONFUSION 7 0.0076
44 CATHETER SITE EXTRAVASATION 3 0.0075
45 NAIL OPERATION 3 0.0072
46 NEUTRALISING ANTIBODIES POSITIVE 3 0.0072
47 PRODUCT CLOSURE ISSUE 4 0.0072
48 CATHETER SITE PRURITUS 6 0.0068
49 VASCULAR DEVICE INFECTION 30 0.0066
50 MYELOSUPPRESSION 238 0.0066
51 TRACHEITIS 5 0.0066
52 CATHETER SITE PAIN 17 0.0065
53 PRODUCT SELECTION ERROR 7 0.0064
54 INFUSION SITE HAEMATOMA 3 0.0063
55 CENTRAL VENOUS CATHETERISATION 19 0.0063
56 PERIARTHRITIS 14 0.0061
57 CATHETER SITE BRUISE 2 0.0060
58 URINARY TRACT PAIN 3 0.0059
59 INFUSION SITE VESICLES 3 0.0057
60 INCORRECT PRODUCT FORMULATION ADMINISTERED 5 0.0056
61 LARYNGEAL DISORDER 4 0.0055
62 CATHETER PLACEMENT 10 0.0054
63 VEIN RUPTURE 9 0.0054
64 ADMINISTRATION SITE PAIN 6 0.0052
65 INFUSION SITE EXTRAVASATION 32 0.0051
66 ASYMPTOMATIC COVID-19 2 0.0051
67 CROUP INFECTIOUS 4 0.0051
68 PRODUCT CONTAMINATION MICROBIAL 6 0.0050
69 CAT SCRATCH DISEASE 2 0.0050
70 INFUSION SITE SWELLING 31 0.0049
71 PRODUCT PREPARATION ISSUE 31 0.0047
72 LARYNGEAL OEDEMA 29 0.0047
73 INSURANCE ISSUE 71 0.0046
74 SPINAL CORD INFECTION 3 0.0046
75 INFUSION SITE URTICARIA 3 0.0045
76 DEVICE RELATED SEPSIS 9 0.0045
77 BLOOD MAGNESIUM INCREASED 4 0.0044
78 ALLERGY TO ARTHROPOD STING 2 0.0044
79 MAST CELL ACTIVATION SYNDROME 6 0.0043
80 HAEMATOLOGICAL INFECTION 10 0.0041
81 CATHETER SITE INFECTION 15 0.0040
82 INFUSION SITE IRRITATION 5 0.0039
83 PRESCRIBED OVERDOSE 74 0.0038
84 IDIOPATHIC URTICARIA 4 0.0037
85 INFUSION SITE REACTION 11 0.0037
86 INFUSION SITE PAIN 47 0.0036
87 INFUSION SITE RASH 5 0.0036
88 HAND-FOOT-AND-MOUTH DISEASE 3 0.0036
89 POOR QUALITY PRODUCT ADMINISTERED 38 0.0036
90 DEVICE RELATED INFECTION 55 0.0036
91 BUNION OPERATION 2 0.0036
92 BLOOD FIBRINOGEN DECREASED 4 0.0035
93 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 19 0.0035
94 NOROVIRUS INFECTION 5 0.0035
95 TENSION 21 0.0034
96 INFUSION SITE INFECTION 8 0.0034
97 INFUSION SITE DISCOLOURATION 3 0.0034
98 FEBRILE INFECTION 4 0.0034
99 PRODUCT CONTAMINATION 12 0.0034
100 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 3 0.0034
101 DEAFNESS NEUROSENSORY 11 0.0033
102 ALLERGY TO METALS 2 0.0033
103 CERUMEN IMPACTION 3 0.0033
104 CATHETER SITE ERYTHEMA 7 0.0033
105 INFUSION SITE WARMTH 4 0.0033
106 ALLERGY TO CHEMICALS 4 0.0032
107 PSYCHOGENIC SEIZURE 3 0.0032
108 OVARIAN CYST RUPTURED 4 0.0031
109 SPINAL LAMINECTOMY 3 0.0031
110 CYSTIC FIBROSIS 17 0.0031
111 INCORRECT DRUG ADMINISTRATION RATE 13 0.0031
112 PHARYNGITIS STREPTOCOCCAL 33 0.0030
113 DEVICE RELATED THROMBOSIS 3 0.0030
114 INFUSION SITE HAEMORRHAGE 10 0.0030
115 DELIVERY 2 0.0030
116 GLYCOSURIA 4 0.0030
117 SIALOADENITIS 4 0.0029
118 PRODUCT LABEL CONFUSION 17 0.0029
119 DERMATITIS CONTACT 32 0.0028
120 RENAL TRANSPLANT 10 0.0028
121 POST PROCEDURAL SWELLING 3 0.0027
122 INFUSION SITE ERYTHEMA 23 0.0027
123 CATHETER SITE DISCHARGE 3 0.0027
124 CARDIAC INFECTION 2 0.0027
125 BLOODY DISCHARGE 3 0.0026
126 WRONG DRUG ADMINISTERED 23 0.0026
127 INFERTILITY FEMALE 4 0.0026
128 PRURITUS ALLERGIC 3 0.0026
129 PRODUCT DEPOSIT 4 0.0026
130 SKIN ABRASION 12 0.0025
131 PHYSICAL PRODUCT LABEL ISSUE 3 0.0025
132 CHRONIC RESPIRATORY FAILURE 3 0.0025
133 WEIGHT FLUCTUATION 26 0.0025
134 DEVICE INFUSION ISSUE 6 0.0024
135 PRODUCT CONTAMINATION PHYSICAL 6 0.0024
136 EXPOSURE TO SARS-COV-2 4 0.0024
137 EXOPHTHALMOS 5 0.0023
138 INFUSION SITE BRUISING 5 0.0023
139 TREATMENT DELAYED 4 0.0023
140 ABSCESS DRAINAGE 2 0.0023
141 INTERCEPTED PRODUCT SELECTION ERROR 3 0.0023
142 INFUSION SITE DISCHARGE 4 0.0023
143 WISDOM TEETH REMOVAL 3 0.0023
144 GASTROENTERITIS VIRAL 40 0.0022
145 MULTIPLE ALLERGIES 17 0.0022
146 POOR QUALITY DRUG ADMINISTERED 14 0.0022
147 DENTAL CARE 4 0.0022
148 SINUS PAIN 5 0.0021
149 APPENDIX DISORDER 3 0.0021
150 OXYGEN SATURATION ABNORMAL 6 0.0021
151 WEIGHT ABNORMAL 5 0.0021
152 BUTTERFLY RASH 2 0.0020
153 PRODUCT COLOUR ISSUE 10 0.0019
154 PRODUCT PREPARATION ERROR 40 0.0019
155 CHEST INJURY 4 0.0019
156 LIQUID PRODUCT PHYSICAL ISSUE 14 0.0019
157 INFUSION SITE PRURITUS 6 0.0019
158 PHARYNGEAL PARAESTHESIA 3 0.0019
159 HYPERPYREXIA 8 0.0019
160 ANIMAL BITE 5 0.0019
161 PARANASAL SINUS DISCOMFORT 7 0.0018
162 DRUG SPECIFIC ANTIBODY PRESENT 12 0.0018
163 RESPIRATORY TRACT INFECTION 48 0.0018
164 SEASONAL ALLERGY 26 0.0018
165 PRODUCT DISTRIBUTION ISSUE 17 0.0018
166 COLONOSCOPY 4 0.0018
167 ARTHROPOD STING 3 0.0018
168 VEIN DISORDER 9 0.0018
169 RHINOVIRUS INFECTION 7 0.0018
170 STREPTOCOCCAL INFECTION 10 0.0018
171 TONSILLAR HYPERTROPHY 3 0.0018
172 PRODUCT LEAKAGE 10 0.0018
173 EAR INFECTION 47 0.0018
174 PRODUCT CONTAINER ISSUE 15 0.0017
175 LIGAMENT SPRAIN 17 0.0017
176 SINUS CONGESTION 23 0.0017
177 INGROWING NAIL 4 0.0017
178 FIBRIN D DIMER INCREASED 6 0.0017
179 JUGULAR VEIN THROMBOSIS 3 0.0017
180 GASTROINTESTINAL INFECTION 15 0.0017
181 PRODUCT LABEL ISSUE 11 0.0016
182 CATHETER SITE HAEMORRHAGE 4 0.0016
183 GINGIVAL RECESSION 3 0.0016
184 HAND FRACTURE 11 0.0016
185 HERNIA REPAIR 4 0.0015
186 URINE OUTPUT INCREASED 4 0.0015
187 COMPLICATION ASSOCIATED WITH DEVICE 22 0.0015
188 EXPOSURE VIA BREAST MILK 6 0.0015
189 NEUTROPHIL COUNT DECREASED 61 0.0015
190 PHARYNGEAL OEDEMA 23 0.0015
191 MATERNAL EXPOSURE DURING BREAST FEEDING 6 0.0015
192 BONE MARROW FAILURE 30 0.0015
193 CARBON DIOXIDE INCREASED 2 0.0015
194 CORNEAL ABRASION 2 0.0015
195 SINUSITIS 148 0.0014
196 ENDOTRACHEAL INTUBATION 4 0.0014
197 EYE CONTUSION 3 0.0014
198 STAPHYLOCOCCAL SEPSIS 7 0.0014
199 AUDITORY DISORDER 2 0.0014
200 GRANULOCYTOPENIA 8 0.0014
201 RESPIRATORY TRACT CONGESTION 22 0.0014
202 DYSPNOEA AT REST 4 0.0014
203 OLIGOMENORRHOEA 3 0.0014
204 ACUTE ABDOMEN 2 0.0014
205 SARS-COV-2 TEST POSITIVE 18 0.0014
206 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 46 0.0014
207 POST PROCEDURAL INFECTION 11 0.0014
208 BACTERAEMIA 16 0.0013
209 INFECTIOUS MONONUCLEOSIS 3 0.0013
210 WRONG PRODUCT ADMINISTERED 9 0.0013
211 PRODUCT STORAGE ISSUE 5 0.0013
212 EMERGENCY CARE 4 0.0013
213 GASTRIC INFECTION 5 0.0013
214 LOCALISED OEDEMA 6 0.0013
215 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
216 ORAL SURGERY 3 0.0013
217 BACTERIAL VAGINOSIS 2 0.0013
218 MUSCLE STRAIN 11 0.0013
219 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 226 0.0013
220 TENDERNESS 13 0.0012
221 DRUG EFFECT INCOMPLETE 45 0.0012
222 ILLNESS 127 0.0012
223 COSTOCHONDRITIS 2 0.0012
224 DERMAL CYST 3 0.0012
225 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
226 HYPERNATRAEMIA 6 0.0012
227 DRUG DISPENSING ERROR 18 0.0012
228 UPPER RESPIRATORY TRACT INFECTION 54 0.0012
229 SKIN INFECTION 13 0.0012
230 HORDEOLUM 5 0.0012
231 TONSILLITIS 6 0.0011
232 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
233 PULMONARY FUNCTION TEST DECREASED 5 0.0011
234 PRODUCT AVAILABILITY ISSUE 26 0.0011
235 DYSPNOEA EXERTIONAL 43 0.0011
236 INFUSION RELATED REACTION 75 0.0011
237 LUNG TRANSPLANT 4 0.0011
238 FOOD POISONING 6 0.0011
239 CARDIAC ABLATION 2 0.0011
240 WEIGHT INCREASED 249 0.0011
241 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 19 0.0011
242 OROPHARYNGEAL DISCOMFORT 10 0.0011
243 RED BLOOD CELL COUNT INCREASED 3 0.0011
244 BODY TEMPERATURE ABNORMAL 2 0.0011
245 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
246 ARTHRITIS INFECTIVE 5 0.0011
247 EAR DISCOMFORT 11 0.0011
248 EYE INFECTION 12 0.0011
249 VIRAL UPPER RESPIRATORY TRACT INFECTION 5 0.0011
250 CLAVICLE FRACTURE 4 0.0010
251 FOOD ALLERGY 8 0.0010
252 SKIN WARM 6 0.0010
253 DEVICE POWER SOURCE ISSUE 3 0.0010
254 HORMONE LEVEL ABNORMAL 5 0.0010
255 AGRANULOCYTOSIS 19 0.0010
256 VIRAL INFECTION 34 0.0010
257 CANDIDA INFECTION 17 0.0010
258 WHITE BLOOD CELL COUNT DECREASED 109 0.0010
259 OBSTRUCTION 4 0.0010
260 WRIST FRACTURE 12 0.0010
261 LIMB INJURY 27 0.0010
262 ENDOCARDITIS 5 0.0010
263 ANAPHYLACTOID REACTION 4 0.0010
264 DIASTOLIC DYSFUNCTION 3 0.0010
265 KIDNEY INFECTION 19 0.0010
266 PARTIAL SEIZURES 5 0.0010
267 PRODUCT PACKAGING ISSUE 9 0.0009
268 NEURALGIA 23 0.0009
269 ARTHROPOD BITE 7 0.0009
270 NO ADVERSE EVENT 171 0.0009
271 FULL BLOOD COUNT DECREASED 19 0.0009
272 LOSS OF THERAPEUTIC RESPONSE 3 0.0009
273 PNEUMONIA VIRAL 3 0.0009
274 SHOULDER OPERATION 4 0.0009
275 HYSTERECTOMY 8 0.0009
276 NASOPHARYNGITIS 170 0.0009
277 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
278 CHEST DISCOMFORT 94 0.0009
279 BACTERIAL INFECTION 17 0.0009
280 PRODUCT DOSE OMISSION ISSUE 267 0.0009
281 ACCIDENT AT WORK 2 0.0009
282 PHYSICAL DISABILITY 4 0.0009
283 CONCUSSION 7 0.0009
284 BACTERIAL TEST POSITIVE 2 0.0009
285 SPINAL OPERATION 11 0.0009
286 BLOOD LOSS ANAEMIA 2 0.0009
287 DRUG EFFECT DELAYED 4 0.0009
288 BODY TEMPERATURE INCREASED 18 0.0009
289 ABDOMINAL DISTENSION 92 0.0009
290 STAPHYLOCOCCAL INFECTION 29 0.0009
291 INFLUENZA 98 0.0009
292 EAR PAIN 17 0.0009
293 LUMBAR VERTEBRAL FRACTURE 4 0.0009
294 ONYCHOCLASIS 6 0.0009
295 NASAL CONGESTION 51 0.0009
296 COVID-19 152 0.0009
297 PRODUCTIVE COUGH 41 0.0009
298 FLANK PAIN 8 0.0009
299 TIBIA FRACTURE 4 0.0009
300 THERMAL BURN 6 0.0008
301 JOINT INJURY 18 0.0008
302 PRODUCT SUPPLY ISSUE 6 0.0008
303 CARDIAC PACEMAKER INSERTION 5 0.0008
304 PROTHROMBIN TIME PROLONGED 5 0.0008
305 WEIGHT DECREASED 230 0.0008
306 PNEUMOTHORAX 13 0.0008
307 SCAR 14 0.0008
308 BREATH SOUNDS ABNORMAL 4 0.0008
309 URINE OUTPUT DECREASED 7 0.0008
310 RETCHING 17 0.0008
311 BRAIN OEDEMA 10 0.0008
312 FOOT FRACTURE 15 0.0008
313 DERMATOMYOSITIS 2 0.0008
314 APPENDICITIS PERFORATED 2 0.0008
315 PARANASAL SINUS HYPERSECRETION 3 0.0008
316 CHILLS 92 0.0008
317 OESOPHAGEAL DISORDER 3 0.0008
318 HAEMOLYSIS 6 0.0008
319 SCRATCH 8 0.0008
320 FURUNCLE 6 0.0008
321 FUNGAL INFECTION 25 0.0007
322 FUNGAL SKIN INFECTION 3 0.0007
323 PRODUCT DOSE OMISSION IN ERROR 21 0.0007
324 BLOOD SODIUM INCREASED 2 0.0007
325 SKIN LACERATION 8 0.0007
326 TACHYPNOEA 10 0.0007
327 CLUMSINESS 2 0.0007
328 CYSTITIS 23 0.0007
329 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
330 DIZZINESS POSTURAL 7 0.0007
331 HEART RATE ABNORMAL 4 0.0007
332 THERAPY CHANGE 7 0.0007
333 MUSCLE FATIGUE 3 0.0007
334 SINUS DISORDER 14 0.0007
335 PAIN IN JAW 20 0.0007
336 PYREXIA 244 0.0007
337 DIALYSIS 10 0.0007
338 LOCALISED INFECTION 17 0.0007
339 PURULENT DISCHARGE 3 0.0007
340 PALLOR 19 0.0007
341 EXERCISE TOLERANCE DECREASED 4 0.0007
342 LIGAMENT RUPTURE 3 0.0007
343 SENSITIVE SKIN 5 0.0007
344 CATHETERISATION CARDIAC 3 0.0007
345 SINUS HEADACHE 4 0.0007
346 ANAPHYLACTIC REACTION 37 0.0007
347 BRAIN HERNIATION 2 0.0007
348 ATYPICAL PNEUMONIA 2 0.0007
349 SYMPTOM RECURRENCE 4 0.0007
350 BLOOD CULTURE POSITIVE 2 0.0007
351 HEART RATE INCREASED 66 0.0007
352 THROAT TIGHTNESS 18 0.0007
353 CONTUSION 64 0.0007
354 SUSPECTED OFF LABEL USE 3 0.0007
355 OSTEOMYELITIS 12 0.0007
356 ABDOMINAL HERNIA 3 0.0007
357 BRONCHITIS 48 0.0006
358 INTERCEPTED MEDICATION ERROR 3 0.0006
359 FEELING COLD 18 0.0006
360 PHARYNGITIS 8 0.0006
361 BURNING SENSATION 45 0.0006
362 WHEEZING 38 0.0006
363 BLOOD BLISTER 2 0.0006
364 DEVICE OCCLUSION 9 0.0006
365 BRAIN FOG 10 0.0006
366 GASTROINTESTINAL PAIN 7 0.0006
367 TOOTH FRACTURE 7 0.0006
368 PRODUCT USE COMPLAINT 10 0.0006
369 BREAST CANCER RECURRENT 2 0.0006
370 BLADDER PAIN 2 0.0006
371 LIMB OPERATION 3 0.0006
372 POST PROCEDURAL COMPLICATION 12 0.0006
373 COLD SWEAT 11 0.0006
374 COUGH 174 0.0006
375 MYASTHENIA GRAVIS 5 0.0006
376 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 44 0.0006
377 HOSPITALISATION 95 0.0006
378 THROMBOSIS 49 0.0006
379 ESCHERICHIA INFECTION 5 0.0006
380 HYPERVOLAEMIA 3 0.0006
381 TOOTH INFECTION 8 0.0006
382 PRODUCT FORMULATION ISSUE 4 0.0006
383 FOOT OPERATION 3 0.0006
384 CORONAVIRUS INFECTION 4 0.0006
385 ANEURYSM 3 0.0006
386 INJECTION SITE INFLAMMATION 3 0.0006
387 PROTEIN URINE PRESENT 3 0.0006
388 PREGNANCY 12 0.0006
389 PRODUCT PRESCRIBING ISSUE 13 0.0006
390 INTENTIONAL DOSE OMISSION 17 0.0006
391 EXPOSURE DURING PREGNANCY 37 0.0006
392 PRODUCT ADMINISTRATION ERROR 12 0.0006
393 POSTOPERATIVE WOUND INFECTION 4 0.0006
394 PRODUCT USE ISSUE 111 0.0006
395 RHINORRHOEA 38 0.0006
396 SWELLING 55 0.0006
397 INFECTION 85 0.0006
398 GINGIVAL BLEEDING 8 0.0006
399 TEMPERATURE INTOLERANCE 6 0.0006
400 SNEEZING 13 0.0006
401 MIGRAINE 55 0.0006
402 SKIN SWELLING 5 0.0006
403 ROAD TRAFFIC ACCIDENT 24 0.0006
404 MASS 8 0.0006
405 MATERNAL EXPOSURE DURING PREGNANCY 51 0.0006
406 INJECTION SITE DISCOMFORT 6 0.0006
407 RESPIRATORY DISORDER 17 0.0006
408 PAPULE 4 0.0006
409 TOOTH EXTRACTION 7 0.0006
410 APPENDICECTOMY 2 0.0006
411 GASTROINTESTINAL DISORDER 50 0.0006
412 MEDICATION ERROR 31 0.0006
413 IMPAIRED QUALITY OF LIFE 8 0.0006
414 ANAL INCONTINENCE 5 0.0006
415 HIP SURGERY 3 0.0006
416 PLATELET COUNT DECREASED 59 0.0006
417 BLOOD PRESSURE ABNORMAL 11 0.0006
418 PULMONARY THROMBOSIS 6 0.0005
419 INJECTION SITE IRRITATION 7 0.0005
420 OROPHARYNGEAL PAIN 50 0.0005
421 DIPLOPIA 14 0.0005
422 NECROSIS 3 0.0005
423 CARDIAC DYSFUNCTION 2 0.0005
424 APPENDICITIS 5 0.0005
425 ANGIOPATHY 3 0.0005
426 PERIORBITAL SWELLING 3 0.0005
427 ADVERSE REACTION 7 0.0005
428 SPUTUM DISCOLOURED 5 0.0005
429 NEPHROLITHIASIS 24 0.0005
430 ELECTROLYTE IMBALANCE 6 0.0005
431 URINARY TRACT INFECTION 87 0.0005
432 HEPATIC FUNCTION ABNORMAL 19 0.0005
433 HEAD DISCOMFORT 9 0.0005
434 BLOOD IRON DECREASED 6 0.0005
435 ANAPHYLACTIC SHOCK 13 0.0005
436 UPPER LIMB FRACTURE 10 0.0005
437 SCIATICA 8 0.0005
438 OVARIAN CYST 5 0.0005
439 CYSTITIS HAEMORRHAGIC 2 0.0005
440 RHINITIS 4 0.0005
441 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
442 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
443 DISCOMFORT 30 0.0005
444 TOOTH ABSCESS 5 0.0005
445 POLYURIA 4 0.0005
446 TRANSFUSION 5 0.0005
447 BLEPHAROSPASM 3 0.0005
448 IMMUNODEFICIENCY 7 0.0005
449 DIVERTICULITIS 13 0.0005
450 ABDOMINAL PAIN 109 0.0005
451 DEVICE ISSUE 42 0.0005
452 PRODUCT USE IN UNAPPROVED INDICATION 116 0.0005
453 UNRESPONSIVE TO STIMULI 12 0.0005
454 NAIL DISORDER 4 0.0005
455 TINNITUS 21 0.0005
456 ORAL CANDIDIASIS 6 0.0005
457 GROIN PAIN 4 0.0005
458 PRODUCT COMMUNICATION ISSUE 4 0.0005
459 EXPIRED PRODUCT ADMINISTERED 15 0.0005
460 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
461 BREAST MASS 3 0.0004
462 NEPHROPATHY TOXIC 5 0.0004
463 BLOOD PRESSURE INCREASED 68 0.0004
464 FALL 148 0.0004
465 HEAD INJURY 14 0.0004
466 VOMITING 207 0.0004
467 ABNORMAL LOSS OF WEIGHT 3 0.0004
468 ULCER 7 0.0004
469 BLOOD PRESSURE DECREASED 29 0.0004
470 BLOOD THYROID STIMULATING HORMONE INCREASED 4 0.0004
471 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
472 HEADACHE 271 0.0004
473 CONJUNCTIVITIS 8 0.0004
474 LACRIMATION INCREASED 13 0.0004
475 SPLENOMEGALY 5 0.0004
476 THROAT IRRITATION 19 0.0004
477 PNEUMONIA 137 0.0004
478 DRUG LEVEL INCREASED 7 0.0004
479 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
480 RASH ERYTHEMATOUS 20 0.0004
481 CELLULITIS 21 0.0004
482 SWOLLEN TONGUE 13 0.0004
483 CHEST PAIN 77 0.0004
484 VISUAL FIELD DEFECT 3 0.0004
485 HERNIA 8 0.0004
486 MOUTH HAEMORRHAGE 3 0.0004
487 PHARYNGEAL SWELLING 4 0.0004
488 FEELING HOT 25 0.0004
489 HEPATOMEGALY 4 0.0004
490 INABILITY TO AFFORD MEDICATION 4 0.0004
491 HYDRONEPHROSIS 3 0.0004
492 HYPOTONIA 4 0.0004
493 LEUKOPENIA 20 0.0004
494 SECRETION DISCHARGE 5 0.0004
495 HYPOAESTHESIA ORAL 6 0.0004
496 DERMATITIS ALLERGIC 5 0.0004
497 HYPOACUSIS 17 0.0004
498 SEPSIS 44 0.0004
499 FEEDING DISORDER 8 0.0004
500 HYPERSENSITIVITY 73 0.0004
501 SLUGGISHNESS 4 0.0004
502 HIP ARTHROPLASTY 6 0.0004
503 DEVICE PHYSICAL PROPERTY ISSUE 3 0.0004
504 OXYGEN SATURATION DECREASED 22 0.0004
505 HYPERBILIRUBINAEMIA 4 0.0004
506 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
507 URTICARIA 64 0.0004
508 AFFECTIVE DISORDER 3 0.0004
509 CYANOSIS 6 0.0004
510 MUSCLE SPASMS 70 0.0004
511 HAEMATURIA 13 0.0004
512 PULMONARY CONGESTION 5 0.0004
513 NASAL DISCOMFORT 3 0.0004
514 JOINT DISLOCATION 4 0.0004
515 VERTIGO 23 0.0004
516 EYE HAEMORRHAGE 5 0.0004
517 FRUSTRATION TOLERANCE DECREASED 3 0.0004
518 HEART RATE DECREASED 13 0.0004
519 BEHAVIOUR DISORDER 2 0.0004
520 BLOOD POTASSIUM INCREASED 6 0.0004
521 PRODUCT QUALITY ISSUE 50 0.0004
522 BACK INJURY 4 0.0004
523 FATIGUE 286 0.0004
524 INJECTION SITE URTICARIA 9 0.0004
525 LIVER INJURY 9 0.0004
526 ABNORMAL FAECES 3 0.0004
527 INTERVERTEBRAL DISC PROTRUSION 8 0.0004
528 BLOOD POTASSIUM DECREASED 11 0.0004
529 MENSTRUAL DISORDER 3 0.0004
530 EMBOLISM 3 0.0004
531 PAIN 221 0.0004
532 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
533 BLOOD UREA INCREASED 6 0.0004
534 HAEMODIALYSIS 3 0.0004
535 PAIN IN EXTREMITY 105 0.0004
536 OCULAR DISCOMFORT 4 0.0004
537 SENSATION OF FOREIGN BODY 3 0.0004
538 FISTULA 4 0.0004
539 LIMB DISCOMFORT 11 0.0004
540 SEIZURE 41 0.0004
541 HEART RATE IRREGULAR 8 0.0004
542 SINUS TACHYCARDIA 5 0.0004
543 DRUG-INDUCED LIVER INJURY 11 0.0004
544 ERYTHEMA 72 0.0003
545 MICTURITION URGENCY 4 0.0003
546 INTERNAL HAEMORRHAGE 4 0.0003
547 PSEUDOMONAS INFECTION 3 0.0003
548 SYNCOPE 35 0.0003
549 HYPERSOMNIA 10 0.0003
550 NAUSEA 275 0.0003
551 CONDITION AGGRAVATED 105 0.0003
552 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
553 HYPERTENSION 73 0.0003
554 FLUSHING 35 0.0003
555 RASH MACULAR 12 0.0003
556 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
557 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
558 INCORRECT DOSE ADMINISTERED 77 0.0003
559 FACIAL PAIN 3 0.0003
560 INJECTION SITE PAIN 103 0.0003
561 ACCIDENT 4 0.0003
562 MYOSITIS 3 0.0003
563 PALPITATIONS 39 0.0003
564 KNEE ARTHROPLASTY 7 0.0003
565 OEDEMA 18 0.0003
566 HERPES ZOSTER 19 0.0003
567 UNEVALUABLE EVENT 25 0.0003
568 WRONG TECHNIQUE IN DRUG USAGE PROCESS 12 0.0003
569 LETHARGY 19 0.0003
570 EATING DISORDER 7 0.0003
571 EYE PRURITUS 11 0.0003
572 PNEUMONIA BACTERIAL 3 0.0003
573 DYSPNOEA 185 0.0003
574 CYTOPENIA 4 0.0003
575 DYSURIA 12 0.0003
576 INJECTION SITE RASH 10 0.0003
577 SKIN CANCER 7 0.0003
578 NERVE COMPRESSION 3 0.0003
579 INTERCEPTED PRODUCT PREPARATION ERROR 4 0.0003
580 PROCEDURAL PAIN 9 0.0003
581 SURGERY 19 0.0003
582 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
583 HYPERCALCAEMIA 4 0.0003
584 ANKLE FRACTURE 5 0.0003
585 BACK PAIN 75 0.0003
586 HAEMOPTYSIS 9 0.0003
587 RENAL DISORDER 15 0.0003
588 MENTAL DISORDER 14 0.0003
589 BRADYCARDIA 17 0.0003
590 DYSARTHRIA 12 0.0003
591 BLOOD SODIUM DECREASED 6 0.0003
592 ABDOMINAL DISCOMFORT 53 0.0003
593 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
594 CHOLESTASIS 6 0.0003
595 LOWER LIMB FRACTURE 6 0.0003
596 CARDIAC FLUTTER 2 0.0003
597 HIATUS HERNIA 4 0.0003
598 MUSCLE TIGHTNESS 5 0.0003
599 ORAL HERPES 6 0.0003
600 VITREOUS FLOATERS 3 0.0003
601 KNEE OPERATION 3 0.0003
602 DIZZINESS 152 0.0003
603 BODY TEMPERATURE DECREASED 3 0.0003
604 ASPERGILLUS INFECTION 2 0.0003
605 LOSS OF CONSCIOUSNESS 39 0.0003
606 PERICARDIAL EFFUSION 7 0.0003
607 POOR QUALITY DEVICE USED 3 0.0003
608 MALIGNANT MELANOMA 4 0.0003
609 QUALITY OF LIFE DECREASED 4 0.0003
610 PERICARDITIS 5 0.0003
611 HYPOTHERMIA 3 0.0003
612 TREMOR 49 0.0003
613 RASH PRURITIC 16 0.0003
614 OCULAR HYPERAEMIA 14 0.0003
615 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 5 0.0003
616 MALAISE 129 0.0003
617 EPISTAXIS 22 0.0003
618 THERAPY INTERRUPTED 21 0.0003
619 HEPATIC ENZYME INCREASED 20 0.0003
620 BLOOD TESTOSTERONE DECREASED 2 0.0003
621 SKIN LESION 8 0.0003
622 COLITIS 11 0.0003
623 EYE DISCHARGE 3 0.0003
624 PULMONARY HYPERTENSION 6 0.0003
625 PRESYNCOPE 7 0.0003
626 PETECHIAE 3 0.0003
627 PRODUCT ODOUR ABNORMAL 3 0.0003
628 CARPAL TUNNEL SYNDROME 4 0.0003
629 PERIPHERAL SWELLING 44 0.0003
630 PRODUCT STORAGE ERROR 25 0.0003
631 NEUROPATHY PERIPHERAL 27 0.0003
632 EYE PAIN 16 0.0003
633 RENAL PAIN 3 0.0003
634 LYMPHADENOPATHY 10 0.0003
635 TACHYCARDIA 25 0.0003
636 LIVER FUNCTION TEST INCREASED 6 0.0003
637 POOR QUALITY SLEEP 6 0.0003
638 PRURITUS 107 0.0003
639 CARDIAC DISORDER 26 0.0003
640 DEHYDRATION 37 0.0003
641 PARAESTHESIA ORAL 4 0.0003
642 ASTHENIA 104 0.0003
643 FLUID RETENTION 14 0.0003
644 RESTLESS LEGS SYNDROME 5 0.0003
645 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
646 NEEDLE ISSUE 8 0.0003
647 RESPIRATORY FAILURE 20 0.0003
648 GASTROENTERITIS 4 0.0003
649 ASPIRATION 3 0.0003
650 ABDOMINAL PAIN UPPER 56 0.0003
651 ARTHRALGIA 113 0.0003
652 BLINDNESS TRANSIENT 2 0.0003
653 MYALGIA 46 0.0003
654 EXPOSURE VIA SKIN CONTACT 7 0.0003
655 TOOTH DISORDER 6 0.0003
656 NERVE INJURY 3 0.0003
657 INTESTINAL OBSTRUCTION 10 0.0003
658 LUNG DISORDER 13 0.0003
659 PANCREATITIS 14 0.0003
660 LOWER RESPIRATORY TRACT INFECTION 12 0.0003
661 SCAB 3 0.0003
662 PROTEINURIA 5 0.0003
663 INJECTION SITE REACTION 18 0.0003
664 BOWEL MOVEMENT IRREGULARITY 2 0.0003
665 SKIN DISCOLOURATION 12 0.0003
666 SWELLING FACE 17 0.0003
667 NEOPLASM 3 0.0003
668 ACUTE RESPIRATORY FAILURE 5 0.0003
669 LUNG INFECTION 4 0.0003
670 DIARRHOEA 166 0.0003
671 ARTHRITIS 20 0.0003
672 COVID-19 PNEUMONIA 3 0.0003
673 HYPOAESTHESIA 38 0.0003
674 DEVICE DISLOCATION 11 0.0003
675 WOUND 7 0.0003
676 PRODUCT PHYSICAL ISSUE 5 0.0002
677 TASTE DISORDER 5 0.0002
678 MUSCULAR WEAKNESS 28 0.0002
679 COLITIS ULCERATIVE 11 0.0002
680 BACK DISORDER 4 0.0002
681 DECUBITUS ULCER 2 0.0002
682 RIB FRACTURE 5 0.0002
683 INJECTION SITE WARMTH 5 0.0002
684 PHOTOSENSITIVITY REACTION 4 0.0002
685 EYE SWELLING 9 0.0002
686 CYST 3 0.0002
687 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
688 SLEEP DISORDER 17 0.0002
689 DRY EYE 12 0.0002
690 PNEUMONIA ASPIRATION 6 0.0002
691 COAGULOPATHY 4 0.0002
692 ANXIETY 68 0.0002
693 INJECTION SITE PRURITUS 16 0.0002
694 RASH 104 0.0002
695 ASCITES 7 0.0002
696 MOUTH ULCERATION 5 0.0002
697 HAEMATEMESIS 6 0.0002
698 CARDIAC FAILURE CONGESTIVE 19 0.0002
699 URINARY INCONTINENCE 7 0.0002
700 HEMIPARESIS 4 0.0002
701 CARDIAC OPERATION 2 0.0002
702 MUSCULOSKELETAL DISCOMFORT 4 0.0002
703 ANURIA 2 0.0002
704 JOINT SWELLING 28 0.0002
705 BLOOD MAGNESIUM DECREASED 2 0.0002
706 PLATELET COUNT INCREASED 3 0.0002
707 NODULE 3 0.0002
708 BLOOD CREATININE INCREASED 15 0.0002
709 FEELING ABNORMAL 55 0.0002
710 PARAESTHESIA 36 0.0002
711 DEVICE USE ISSUE 4 0.0002
712 INCORRECT PRODUCT STORAGE 3 0.0002
713 BLOOD CALCIUM INCREASED 2 0.0002
714 GASTRITIS 6 0.0002
715 ANGIOEDEMA 10 0.0002
716 GALLBLADDER DISORDER 4 0.0002
717 CEREBRAL HAEMORRHAGE 8 0.0002
718 RASH PAPULAR 5 0.0002
719 DEVELOPMENTAL DELAY 2 0.0002
720 OEDEMA PERIPHERAL 27 0.0002
721 LEUKOCYTOSIS 4 0.0002
722 DRUG TOXICITY 3 0.0002
723 CRYING 8 0.0002
724 HYPERGLYCAEMIA 8 0.0002
725 VISION BLURRED 30 0.0002
726 RESPIRATORY ARREST 6 0.0002
727 RESPIRATORY DISTRESS 6 0.0002
728 MUSCLE TWITCHING 5 0.0002
729 POLLAKIURIA 9 0.0002
730 HUNGER 3 0.0002
731 APHONIA 3 0.0002
732 NECK PAIN 12 0.0002
733 HAEMOGLOBIN DECREASED 22 0.0002
734 SKIN REACTION 3 0.0002
735 PHOTOPHOBIA 4 0.0002
736 ASTHMA 24 0.0002
737 ADVERSE DRUG REACTION 19 0.0002
738 DYSPHAGIA 20 0.0002
739 BLOOD URINE PRESENT 4 0.0002
740 HAEMORRHAGE 22 0.0002
741 RED BLOOD CELL COUNT DECREASED 6 0.0002
742 HYPERHIDROSIS 27 0.0002
743 INJECTION SITE SWELLING 16 0.0002
744 EYE IRRITATION 12 0.0002
745 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
746 AFFECT LABILITY 2 0.0002
747 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
748 ATELECTASIS 2 0.0002
749 ADVERSE EVENT 19 0.0002
750 ATRIAL FIBRILLATION 20 0.0002
751 AUTOIMMUNE DISORDER 2 0.0002
752 DYSPHONIA 12 0.0002
753 HAEMORRHOIDS 4 0.0002
754 CHOKING 4 0.0002
755 HYPOTENSION 41 0.0002
756 GASTRIC DISORDER 7 0.0002
757 COELIAC DISEASE 2 0.0002
758 DYSPEPSIA 20 0.0002
759 SKIN HAEMORRHAGE 3 0.0002
760 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
761 HAEMATOCRIT DECREASED 4 0.0002
762 INJECTION SITE ERYTHEMA 25 0.0002
763 BLADDER DISORDER 2 0.0002
764 PULMONARY MASS 3 0.0002
765 HAEMORRHAGE INTRACRANIAL 3 0.0002
766 HEPATIC FAILURE 6 0.0002
767 PROSTATE CANCER 16 0.0002
768 HYPOXIA 7 0.0002
769 APHASIA 6 0.0002
770 ECONOMIC PROBLEM 3 0.0002
771 ARTHROPATHY 11 0.0002
772 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
773 OFF LABEL USE 172 0.0002
774 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
775 INFLUENZA LIKE ILLNESS 16 0.0002
776 ANAEMIA 37 0.0002
777 FLATULENCE 11 0.0002
778 MUSCULOSKELETAL CHEST PAIN 3 0.0002
779 INFLAMMATION 10 0.0002
780 EJECTION FRACTION DECREASED 3 0.0002
781 NERVOUS SYSTEM DISORDER 6 0.0002
782 SPEECH DISORDER 10 0.0002
783 ARRHYTHMIA 9 0.0002
784 INJECTION SITE MASS 7 0.0002
785 DEPRESSED MOOD 10 0.0002
786 OBESITY 3 0.0002
787 ABSCESS 3 0.0002
788 SENSORY DISTURBANCE 3 0.0002
789 GASTROOESOPHAGEAL REFLUX DISEASE 15 0.0002
790 BREAST CANCER METASTATIC 2 0.0002
791 INJURY 13 0.0002
792 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
793 ILL-DEFINED DISORDER 11 0.0002
794 DECREASED APPETITE 42 0.0002
795 NEOPLASM MALIGNANT 12 0.0002
796 GAIT INABILITY 6 0.0002
797 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
798 FACE OEDEMA 3 0.0002
799 CHROMATURIA 4 0.0002
800 SKIN IRRITATION 8 0.0002
801 EXTRA DOSE ADMINISTERED 7 0.0002
802 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
803 LOCAL SWELLING 3 0.0002
804 LIVER FUNCTION TEST ABNORMAL 5 0.0002
805 CAESAREAN SECTION 2 0.0002
806 MUSCULOSKELETAL STIFFNESS 15 0.0002
807 DERMATITIS ATOPIC 9 0.0002
808 LYMPHOCYTE COUNT DECREASED 3 0.0002
809 CARDIAC ARREST 14 0.0002
810 ACUTE MYOCARDIAL INFARCTION 5 0.0002
811 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
812 PSYCHOTIC DISORDER 5 0.0002
813 DRUG ERUPTION 3 0.0002
814 PRODUCT PRESCRIBING ERROR 4 0.0002
815 GOUT 3 0.0002
816 BLOOD PRESSURE FLUCTUATION 4 0.0002
817 TOOTHACHE 3 0.0002
818 MENTAL IMPAIRMENT 4 0.0002
819 BURSITIS 2 0.0002
820 END STAGE RENAL DISEASE 3 0.0002
821 SOMNOLENCE 33 0.0002
822 RECTAL HAEMORRHAGE 7 0.0002
823 CARDIOMEGALY 2 0.0002
824 ABNORMAL WEIGHT GAIN 2 0.0002
825 SEPTIC SHOCK 7 0.0002
826 BLISTER 9 0.0002
827 BLOOD GLUCOSE INCREASED 30 0.0002
828 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
829 GASTRIC ULCER 3 0.0002
830 SLEEP APNOEA SYNDROME 3 0.0002
831 HYPOPHAGIA 4 0.0002
832 THERAPY CESSATION 8 0.0002
833 GENERAL PHYSICAL HEALTH DETERIORATION 18 0.0002
834 ERUCTATION 3 0.0002
835 DYSTONIA 3 0.0002
836 HAEMATOMA 4 0.0002
837 SKIN EXFOLIATION 13 0.0002
838 DEAFNESS 4 0.0002
839 ECZEMA 8 0.0002
840 MEMORY IMPAIRMENT 21 0.0002
841 MUSCULOSKELETAL PAIN 8 0.0002
842 JOINT STIFFNESS 4 0.0002
843 CHOLELITHIASIS 5 0.0002
844 EYE DISORDER 5 0.0002
845 DISORIENTATION 6 0.0002
846 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
847 BALANCE DISORDER 13 0.0002
848 LIP SWELLING 5 0.0001
849 SKIN DISORDER 5 0.0001
850 DRY SKIN 20 0.0001
851 IRRITABILITY 9 0.0001
852 CARDIAC FAILURE 12 0.0001
853 TYPE 2 DIABETES MELLITUS 5 0.0001
854 INTENTIONAL PRODUCT USE ISSUE 13 0.0001
855 INJURY ASSOCIATED WITH DEVICE 3 0.0001
856 CONSTIPATION 32 0.0001
857 GAIT DISTURBANCE 28 0.0001
858 CORONARY ARTERY OCCLUSION 2 0.0001
859 BLOOD TEST ABNORMAL 2 0.0001
860 HYPONATRAEMIA 8 0.0001
861 RENAL FAILURE ACUTE 6 0.0001
862 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
863 IRRITABLE BOWEL SYNDROME 3 0.0001
864 NEUTROPENIA 19 0.0001
865 MOBILITY DECREASED 10 0.0001
866 PRURITUS GENERALISED 3 0.0001
867 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
868 VAGINAL HAEMORRHAGE 6 0.0001
869 ANOSMIA 2 0.0001
870 PANIC ATTACK 5 0.0001
871 APATHY 2 0.0001
872 DYSSTASIA 4 0.0001
873 PULMONARY EMBOLISM 13 0.0001
874 CARDIOMYOPATHY 2 0.0001
875 TRANSAMINASES INCREASED 3 0.0001
876 RASH MACULO-PAPULAR 3 0.0001
877 DRUG INEFFECTIVE 176 0.0001
878 EPILEPSY 4 0.0001
879 SHOCK 3 0.0001
880 DRUG ADMINISTRATION ERROR 4 0.0001
881 HYPOKALAEMIA 6 0.0001
882 ACUTE MYELOID LEUKAEMIA 2 0.0001
883 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
884 PANCYTOPENIA 7 0.0001
885 THROMBOCYTOPENIA 14 0.0001
886 METABOLIC ACIDOSIS 4 0.0001
887 CEREBROVASCULAR ACCIDENT 21 0.0001
888 EMOTIONAL DISTRESS 15 0.0001
889 LACTIC ACIDOSIS 4 0.0001
890 FIBROMYALGIA 3 0.0001
891 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 25 0.0001
892 BLINDNESS 5 0.0001
893 IMPAIRED HEALING 4 0.0001
894 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
895 BONE PAIN 7 0.0001
896 HOT FLUSH 9 0.0001
897 ABDOMINAL PAIN LOWER 3 0.0001
898 CARDIOVASCULAR DISORDER 3 0.0001
899 CATARACT 7 0.0001
900 CIRCULATORY COLLAPSE 2 0.0001
901 THERAPEUTIC RESPONSE DECREASED 7 0.0001
902 DEVICE DEFECTIVE 2 0.0001
903 DEVICE LEAKAGE 5 0.0001
904 DEVICE USE ERROR 4 0.0001
905 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
906 INJECTION SITE BRUISING 9 0.0001
907 LIVER DISORDER 5 0.0001
908 SKIN BURNING SENSATION 8 0.0001
909 PULMONARY OEDEMA 5 0.0001
910 BLOOD BILIRUBIN INCREASED 3 0.0001
911 TREATMENT NONCOMPLIANCE 6 0.0001
912 ACCIDENTAL OVERDOSE 4 0.0001
913 DEEP VEIN THROMBOSIS 7 0.0001
914 DYSGEUSIA 8 0.0001
915 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
916 DIABETES MELLITUS 8 0.0001
917 DEATH 89 0.0001
918 HYPOGLYCAEMIA 5 0.0001
919 LABORATORY TEST ABNORMAL 3 0.0001
920 INSOMNIA 27 0.0001
921 INJECTION SITE HAEMORRHAGE 8 0.0001
922 CYTOKINE RELEASE SYNDROME 2 0.0001
923 PREMATURE BABY 3 0.0001
924 CONFUSIONAL STATE 16 0.0001
925 STOMATITIS 6 0.0001
926 PLEURAL EFFUSION 6 0.0001
927 OSTEOPOROSIS 4 0.0001
928 FEMUR FRACTURE 3 0.0001
929 NERVOUSNESS 5 0.0001
930 CARDIO-RESPIRATORY ARREST 4 0.0001
931 DERMATITIS 2 0.0001
932 RENAL IMPAIRMENT 8 0.0001
933 NIGHT SWEATS 3 0.0001
934 DISTURBANCE IN ATTENTION 5 0.0001
935 DEPRESSION 21 0.0001
936 AMNESIA 6 0.0001
937 HAEMATOCHEZIA 5 0.0001
938 VISUAL ACUITY REDUCED 3 0.0001
939 URINARY RETENTION 3 0.0001
940 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
941 THERAPY NON-RESPONDER 4 0.0001
942 CONVULSION 5 0.0001
943 HYPERKALAEMIA 3 0.0001
944 DEVICE MALFUNCTION 6 0.0001
945 ACUTE KIDNEY INJURY 13 0.0001
946 DISEASE PROGRESSION 10 0.0001
947 BLOOD GLUCOSE DECREASED 4 0.0001
948 RENAL FAILURE 11 0.0001
949 DRUG INTOLERANCE 8 0.0001
950 UNDERDOSE 6 0.0001
951 CEREBRAL INFARCTION 2 0.0001
952 AGITATION 6 0.0001
953 ALOPECIA 16 0.0001
954 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
955 AGEUSIA 2 0.0001
956 RHEUMATOID ARTHRITIS 9 0.0001
957 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
958 ABORTION SPONTANEOUS 3 0.0001
959 DRUG EFFECT DECREASED 4 0.0001
960 DEVICE BREAKAGE 3 0.0001
961 DEMENTIA 2 0.0001
962 ANGINA PECTORIS 2 0.0001
963 ACNE 5 0.0001
964 BLOOD CHOLESTEROL INCREASED 3 0.0001
965 COGNITIVE DISORDER 3 0.0001
966 MYOCARDIAL INFARCTION 11 0.0001
967 FEBRILE NEUTROPENIA 4 0.0001
968 ANGER 2 0.0001
969 DELIRIUM 2 0.0001
970 INTENTIONAL PRODUCT MISUSE 5 0.0001
971 VISUAL IMPAIRMENT 7 0.0001
972 C-REACTIVE PROTEIN INCREASED 2 0.0001
973 BREAST CANCER 5 0.0001
974 HALLUCINATION 4 0.0001
975 ABNORMAL BEHAVIOUR 2 0.0001
976 PRODUCT DOSE OMISSION 3 0.0000
977 SUICIDAL IDEATION 4 0.0000
978 COMA 2 0.0000
979 COLORECTAL CANCER 2 0.0000
980 OVERDOSE 9 0.0000
981 CHRONIC KIDNEY DISEASE 3 0.0000
982 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
983 PSORIASIS 5 0.0000
984 DRY MOUTH 3 0.0000
985 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
986 DRUG DOSE OMISSION 6 0.0000
987 TOXICITY TO VARIOUS AGENTS 5 0.0000